August 8, 2020

Volume X, Number 221

August 07, 2020

Subscribe to Latest Legal News and Analysis

August 06, 2020

Subscribe to Latest Legal News and Analysis

Motion to Add Willful Infringement Charge Based Entirely on Post-Suit Activity Is Granted…Because It Is Unopposed

On June 26, 2020, the U.S. District Court for the District of Delaware, in VLSI Tech. LLC. v. Intel Corp, No. 18-0966-CFC, denied VLSI’s motion for leave to amend to add claims for willful infringement of U.S. Patent Nos. 6,212,633 (the “’633 patent”) and 7,523,331 (“the ’331 Patent”) based on pre-suit activity but granted it as to alleged post-suit infringement (which Intel did not oppose). The patents concern secured communications between devices coupled to “memory-mapped” serial communications interfaces and power saving cache memory operations, respectively. VLSI alleged that Intel induced infringement by selling products along with the specific intent to encourage and facilitate infringing uses by its customers, including those in the United States. Intel had previously successfully moved the Court to dismiss indirect infringement allegations of the same two patents as well as claims for enhanced damages based on VLSI’s allegation that Intel’s infringement of those patents was willful. In its original complaint, VLSI alleged that Intel had been willfully blind to the existence of the asserted patents that Intel itself had cited while prosecuting its own patents.  VLSI also contends that Intel’s publicly-known corporate policy forbidding its employees from reading patents held by outside companies or individuals constituted willful blindness.

The Court denied VLSI’s request to add willfulness claims based on alleged pre-suit infringing activity. The Court noted that claims for enhanced damages may proceed beyond the pleading stage only if the pleading alleges facts from which it can be plausibly inferred that the party accused of infringement had knowledge of the asserted patent and knowledge of its infringement.  Calling VLSI’s attempts futile, the Court concluded that “VLSI’s proposed amended complaint does not plausibly allege that Intel knew of or was willfully blind to Intel’s infringement of” the ’633 and ’331 patents. VLSI’s amended complaint alleged that Intel monitored its competitors’ activities, including the prior assignee of the ’633 and ’331 patents, NXP. VLSI also alleged that that Intel knew its competitors “may have” patents covering Intel’s similar products and that Intel previously engaged NXP to acquire “other” NXP patents. But the Court found that none of that alleged activity could plausibly establish that Intel had knowledge that it was infringing the ’633 and ’331 patents. Specifically, the Court concluded that “having a general policy with respect to thousands of patents in a field of technology does not plausibly establish or imply that Intel subjectively believed there was a high probability that its acts constituted infringement of two specific patents.”

However, the Court went on to grant VLSI’s request to add claims of indirect and willful infringement based on alleged post-suit infringement. Intel had only objected to VLSI’s request to the extent it involved the ’633 patent, which expired before the lawsuit was filed. Citing to case law including its own prior decision in the case holding that “the complaint itself cannot serve as the basis for a defendant’s actionable knowledge,” the Court appeared poised to deny VLSI’s request to amend based on that post-suit activity as well. But the court considered that request to be unopposed, commenting that “[f]or reasons not clear from the record, Intel has not objected to VLSI’s remaining claims for post-suit indirect infringement and enhanced damages based on post-suit willful infringement.” On these specific facts, the Court granted VLSI’s indirect infringement and willfulness claims based on Intel’s conduct beginning at the time the suit commenced. This decision reminds defendants facing a motion to amend to add allegations of willfulness that many courts will not consider post-complaint knowledge as a basis for that claim, but only if the motion is opposed.

©1994-2020 Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. All Rights Reserved.National Law Review, Volume X, Number 184

TRENDING LEGAL ANALYSIS


About this Author

Adam Samansky IP Attorney Mintz Law Firm
Member

Adam is an experienced IP litigator who primarily serves pharmaceutical, medical, high tech, and defense industry clients. He handles patent, trademark, and trade secret matters for innovators and investors. Adam has a strong record of success in multiparty, highly contested Hatch-Waxman litigation, in addition to other litigations involving advanced biochemistry, polymers, optics, manufacturing processes, and electronics. He has tried cases before multiple US district courts, briefed and argued cases before the US Court of Appeals for the Federal Circuit, and briefed bet-the-company...

617-348-1819
Peter J. Cuomo, Mintz Levin, Patent Litigation Lawyer, Expert Discovery Attorney,Patent Litigation IPRs & Other Post-Grant Proceedings Federal Circuit Appeals Hatch-Waxman ,ANDA Litigation Federal District Court
Of Counsel

Peter’s practice involves intellectual property enforcement and defense, and client counseling on issues related to IP rights. Peter's primary focus is in patent litigation where he has experience in every phase from pre-suit investigations through appeal, including, initial evaluation and case initiation, fact and expert discovery, pre-and post-trial motion practice, and trials and appeals. In addition to suits centered on the assertion and defense of infringement claims, Peter has experience with the successful resolution of multiple inventorship disputes and related misappropriation claims.

Peter has represented clients across a wide range of technologies such as biotechnology inventions, automotive parts, medical and mechanical devices, consumer products. He has also worked on numerous high-stakes Hatch-Waxman litigations for major pharmaceutical companies through trial and appeals. In addition to patent litigation, Peter has experience in disputes involving breach of contracts, unfair competition, trademarks and trade secret misappropriation claims.

Peter is a registered patent attorney licensed to practice and argue before the United States Patent and Trademark Office. In addition to representing clients in US District Courts and the US Court of Appeals for the Federal Circuit, he has experience in multiple post-grant proceedings before the Patent Trial and Appeal Board and its predecessor. He also provides patent and product analyses, and evaluations of prior art related to infringement and invalidity opinions.

Prior to joining the firm, he practiced in the intellectual property litigation practice in the Boston office of another international law firm. Peter also previously worked in and supervised an academic laboratory focused on researching infectious diseases. He is a co-author on multiple scientific papers and spent time in Zambia investigating the co-infection of measles and HIV. During law school, Peter was an editor on the Boston University Journal of Science and Technology Law and worked as a research assistant in intellectual property and the Health Law Department.

617-348-1854
Joseph Rutowski IP Attorney Mintz
Associate

Joseph’s practice focuses on intellectual property litigation and counseling on issues related to intellectual property rights. Joseph’s primary focus is in patent litigation, including the intricacies of Hatch-Waxman pharmaceutical litigation. He has extensive experience in every stage of litigation, from pre-suit investigations through appeal – including case initiation, fact and expert discovery, motion practice, and successful preparation for and participation in trials involving patent infringement allegations.

Joseph has represented...

617.348.1873